By Andrew Karp
Friday, December 3, 2021 8:30 AM
New contact lens technology to help diagnose and monitor glaucoma and other ocular health conditions may soon be ready for clinical trials. A team of researchers from
Purdue University worked with biomedical, mechanical and chemical engineers, along with clinicians, to develop the novel technology. The team enabled commercial soft contact lenses to be a bioinstrumentation tool for unobtrusive monitoring of clinically important information associated with underlying eye health conditions. “This technology will be greatly beneficial to the painless diagnosis or early detection of many ocular diseases including glaucoma,” said Purdue’s Chi Hwan Lee.
By Staff
Friday, December 3, 2021 12:30 AM
COLUMBUS, Ohio—Columbus-based ophthalmic medtech startup
OcuDoc has named veteran optical industry executive Grady Lenski as chief executive officer. In his new role, Lenski will draw on his extensive experience and deep relationships across the industry to help the firm launch and market a mobile autorefractor known as OcuDoc Mobile that is developing. “Grady is a globally-minded optical industry executive with experience in the C-suite, as a board member, and as consultant for several world-class organizations—he’s the perfect leader for the team as it finalizes development and commercial planning,” emphasized OcuDoc board member and optical industry trailblazer, E. Dean Butler.
By Staff
Wednesday, December 1, 2021 12:24 AM
CHICAGO—
Prevent Blindness is announcing the launch of the first-ever Geographic Atrophy (GA) Awareness Week, to be held Dec. 6-12, 2021.
By Staff
Wednesday, December 1, 2021 12:21 AM
HENDERSON, Nev.—
Evoq, a medical technology startup based here, announced the FDA registration of the first in its family of products based on its proprietary smartphone-based biosensor technology.
By Staff
Monday, November 29, 2021 12:21 AM
RANCHO CORDOVA, Calif.—A new study released by
VSP Vision Care shows that VSP Vision Care members are “generally healthier and incur fewer health care costs linked to chronic conditions like diabetes and hypertension when compared to members of other vision plans nationwide.”
By Staff
Tuesday, November 23, 2021 12:27 AM
NEW YORK—
Vision Monday and
20/20 Magazine are pleased to announce the selections in the 13th annual EyeVote Readers’ Choice Awards, a special survey aimed at identifying readers’ favorite products and companies of the year. Optical retailers and ECP readers of the two Jobson Medical Information publications were asked to identify their “favorite” products in 20 distinct categories. Selected companies were chosen based on both brand and company choices supplied by readers. This year’s survey spanned a wide range of product brands and product groups.
By Staff
Tuesday, November 23, 2021 12:18 AM
SAN RAMON, Calif.—
CooperVision has launched the CooperVision Student Myopia Leadership Society, an initiative that the company said will impact the eyecare profession and patients for decades to come.
By Staff
Tuesday, November 16, 2021 12:21 AM
CHICAGO—
Prevent Blindness has declared Nov. 14-20, 2021 as the second annual “Thyroid Eye Disease Awareness (TED) Week.”
By Staff
Friday, November 12, 2021 12:27 AM
MENLO PARK, Calif.—
Sight Sciences (Nasdaq: SGHT) announced on Wednesday that the Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) authorizing the company to conduct a clinical study to assess the safety and effectiveness of a new, higher volume, investigational OMNI device to perform canal viscodilation alone to lower intraocular pressure (IOP) in adults with primary open-angle glaucoma (POAG).
By Staff
Thursday, November 11, 2021 12:24 AM
GENEVA—
Alcon (SIX/NYSE:ALC) reported worldwide sales of $2.1 billion, an increase of 15 percent on a reported basis and 14 percent on a constant currency basis, for the third quarter ended Sept. 30, 2021 versus the same quarter of the previous year, according to an announcement.
By Staff
Wednesday, November 10, 2021 12:15 AM
SOUTHLAKE, Texas—
TearLab Corp., an ophthalmic diagnostics company that develops and markets laboratory point of care technologies that enable ECPs to improve standard of care, has added James V. Mazzo to the company's board of directors.
By Staff
Tuesday, November 9, 2021 12:24 AM
GENEVA—
Alcon (SIX/NYSE: ALC), a global eyecare company, announced on Monday its intention to acquire
Ivantis, developer and manufacturer of the novel Hydrus Microstent, a minimally-invasive glaucoma surgery (MIGS) device designed to lower intraocular pressure for open-angle glaucoma patients in connection with cataract surgery.